
BXP (BXP) is drawing attention after a period of weaker share performance, with the stock showing a 10.7% decline over the past month and a 23.3% decline over the past 3 months.
See our latest analysis for BXP.
At a share price of US$53.16, BXP’s recent 1 month share price return of 10.7% decline and year to date share price return of 21.6% decline sit alongside a 1 year total shareholder return of 18.3% decline and a 3 year total shareholder return of 16.4% gain. This suggests shorter term momentum has faded compared with the longer term picture.
If this kind of reset has you thinking about where else value or growth stories might emerge, it could be worth scanning 20 top founder-led companies
With BXP trading at US$53.16 and sitting at a 36.1% discount to the current analyst price target, the key question is whether this gap reflects undervaluation or whether the market is already factoring in future growth.
At a last close of $53.16 versus a fair value estimate of $73.15, the most widely followed narrative frames BXP as materially undervalued and links that gap to how its gateway office portfolio could support future cash flows.
BXP's aggressive capital recycling and asset sales strategy (targeting $600 million in non-core dispositions), along with redevelopment and adaptive reuse of assets for mixed-use and multifamily, is expected to unlock higher-yielding income streams, fortify net margins, and provide non-dilutive funding for growth, supporting future FFO and earnings resilience.
Want to see what sits behind that fair value gap? The narrative leans on measured revenue growth, firmer margins, and a future earnings multiple that depends on execution. Curious which assumptions really move the model?
Result: Fair Value of $73.15 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on office demand not weakening further, and on large projects like 343 Madison avoiding cost overruns or delays that could pressure returns.
Find out about the key risks to this BXP narrative.
The earlier fair value estimate points to BXP trading at a 35.3% discount to an intrinsic value of $82.14, based on our DCF model. That suggests the current $53.16 price may not fully reflect the cash flows analysts expect. The open question is whether those assumptions prove realistic or too hopeful.
Look into how the SWS DCF model arrives at its fair value.
With mixed signals on value and sentiment throughout, now is a good time to review the full picture for yourself and move quickly if needed by weighing the 4 key rewards and 4 important warning signs
If BXP has you rethinking your watchlist, now is the moment to broaden your view with fresh ideas that match the kind of portfolio you want.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com